文献速递甲状腺疾病

机器学习预测儿童甲状腺结节恶性风险:临床决策支持的早期经验

Predicting Malignancy in Pediatric Thyroid Nodules: Early Experience With Machine Learning for Clinical Decision Support.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

本研究在三级儿童医院开发机器学习工具,整合人口学、超声和活检数据预测甲状腺结节非良性细胞学和组织学。随机森林模型在67例活检预测和53例手术预测中显示假阳性率改善和准确率提升,但假阴性率有所增加,且样本量小、结果仅为估计值,未经独立验证。

要点

  • 机器学习模型可整合临床数据预测儿童甲状腺结节恶性风险。
  • 模型在活检预测中假阳性率改善68.04%,准确率提高11.90%。
  • 样本量小且未独立验证,改善为估计值,需谨慎解读。

核心结论

  • 机器学习工具首次尝试用于儿童甲状腺结节恶性预测,模型在假阳性率和准确率上有改善,但假阴性率增加且样本量小。

研究设计与样本

  • 回顾性研究,使用随机森林(增强特征选择)和可解释规则集,纳入18岁以下儿童甲状腺结节的人口学、超声和活检数据,来自三级儿童医院。

主要发现

  • 活检预测(67例,28例良性、39例非良性):假阳性率改善68.04%,准确率提高11.90%,AUROC提高24.85%。
  • 手术预测(53例,42例良性、11例非良性):假阳性率降低23.22%,准确率提高32.19%,AUROC降低3.84%。
  • 假阴性率:预计10.27%的恶性患者被建议不做活检,11.67%被建议不做手术。

临床怎么用

  • 该工具尚处于早期开发阶段,不能直接用于临床决策,需更多数据和独立验证。

局限性

  • 样本量小,改善为估计值,未在独立测试集上验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop a machine learning tool to integrate clinical data for the prediction of non-benign thyroid cytology and histology. CONTEXT: Papillary thyroid carcinoma is the most common endocrine malignancy. Since most nodules are benign, the challenge for the clinician is to identify those most likely to harbor malignancy while limiting exposure to surgical risks among those with benign nodules. METHODS: Random forests (augmented to select features based on our clinical measure of interest), in conjunction with interpretable rule sets, were used on demographic, ultrasound, and biopsy data of thyroid nodules from children younger than 18 years at a tertiary pediatric hospital. Accuracy, false-positive rate (FPR), false-negative rate (FNR), and area under the receiver operator curve (AUROC) are reported. RESULTS: Our models predict nonbenign cytology and malignant histology better than historical outcomes. Specifically, we expect a 68.04% improvement in the FPR, 11.90% increase in accuracy, and 24.85% increase in AUROC for biopsy predictions in 67 patients (28 with benign and 39 with nonbenign histology). We expect a 23.22% decrease in FPR, 32.19% increase in accuracy, and 3.84% decrease in AUROC for surgery prediction in 53 patients (42 with benign and 11 with nonbenign histology). This improvement comes at the expense of the FNR, for which we expect 10.27% with malignancy would be discouraged from performing biopsy, and 11.67% from surgery. Given the small number of patients, these improvements are estimates and are not tested on an independent test set. CONCLUSION: This work presents a first attempt at developing an interpretable machine learning based clinical tool to aid clinicians. Future work will involve sourcing more data and developing probabilistic estimates for predictions.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Radebe L, van der Kaay DCM, Wasserman JD, et al. Predicting Malignancy in Pediatric Thyroid Nodules: Early Experience With Machine Learning for Clinical Decision Support. J Clin Endocrinol Metab. 2021. PMID: 34160618. doi:10.1210/clinem/dgab435

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。